Ergoloid Mesylates

ANDA 87233, held by Watson Labs. Ergoloid Mesylates.

As of Nov 15, 2026, ANDA 87233 (Ergoloid Mesylates), held by Watson Labs, was first approved by FDA on Apr 16, 1981, with 7 approved supplements and 0 published complete response letters.

First approved: Apr 16, 1981
Supplements approved: 7
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 8 submissions below

Date	Submission	Status	Documents
Apr 16, 1981	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Ergoloid Mesylates0.5MG · tablet;sublingual	Ergoloid Mesylates	Discontinued

All 8 submissions, including labeling and manufacturing supplements


May 31, 1991	Supplement 13Manufacturing	Approved	None posted
Nov 19, 1990	Supplement 14Manufacturing	Approved	None posted
Jun 29, 1990	Supplement 12Manufacturing	Approved	None posted
Feb 7, 1989	Supplement 11Labeling	Approved	None posted
Dec 6, 1988	Supplement 8Labeling	Approved	None posted
Aug 5, 1988	Supplement 9Manufacturing	Approved	None posted
Jul 9, 1985	Supplement 6Manufacturing	Approved	None posted
Apr 16, 1981	Original application	Approved	None posted

Identifiers

Application: ANDA 87233
Drugs@FDA: Overview at FDA
Company: Watson Laboratories

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters